Grants and Contributions:
Agreement Number:
-
Agreement Value:
$910,350.00
Agreement Date:
Apr 1, 2018 - Mar 31, 2023
Description:
Enhancing ovarian cancer immunogenicity by increasing antitumoral responses using engineered oncolytic vaccines
Organization:
Canadian Institutes of Health Research
Location:
Ottawa, Ontario, CA K1Y 4E9
Reference Number:
236-2017-2018-Q4-00108
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2018-19 to 2022-23)
Recipient's Legal Name:
Vanderhyden, Barbara C
Research Organization:
Ottawa Hospital Research Institute|Institut de recherche de l’Hôpital d’Ottawa